You are viewing an incomplete version of our website. Please click to reload the website as full version.

anti-ADAM Metallopeptidase with Thrombospondin Type 1 Motif, 13 (ADAMTS13) Antikörper

ADAMTS13 encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motif) protein family. Zusätzlich bieten wir Ihnen ADAMTS13 Kits (30) und ADAMTS13 Proteine (6) und viele weitere Produktgruppen zu diesem Protein an.

Alle Antikörper anzeigen Gen GeneID UniProt
ADAMTS13 279028 Q769J6
ADAMTS13 11093 Q76LX8
ADAMTS13 362091  
Direkt bei antikoerper-online bestellen
  • +49 (0)241 95 163 153
  • +49 (0)241 95 163 155
  • Online bestellen
  • orders@antikoerper-online.de

Top anti-ADAMTS13 Antikörper auf antikoerper-online.de

Showing 10 out of 94 products:

Katalog Nr. Reaktivität Wirt Konjugat Applikation Bilder Menge Anbieter Lieferzeit Preis Details
Human Kaninchen Unkonjugiert EIA, IHC (p), WB Immunohistochemistry: ADAMTS13 antibody staining of Formalin-Fixed Paraffin-Embedded Human hepatocarcinoma followed by peroxidase-conjugation to the secondary antibody and DAB staining. Western blot analysis: ADAMTS13 antibody staining of CEM cell line lysates (35 µg/lane). ADAMTS13 (arrow) was detected using the purified Pab. 0.4 mL Anmelden zum Anzeigen 7 bis 9 Tage
407,00 €
Details
Human Kaninchen Unkonjugiert IHC (p), WB Western blot analysis of anti-ADAMTS13 Antibody (Center)(ABIN391641) in CEM cell line lysates (35 µg/lane). ADAMTS13 (arrow) was detected using the purified polyclonal antibody. Formalin-fixed and paraffin-embedded human hepatocarcinoma with ADAMTS13 Antibody (Center), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. 400 μL Anmelden zum Anzeigen 14 bis 16 Tage
335,24 €
Details
Human Kaninchen Unkonjugiert WB Detection of Recombinant Human Adam-TS13 by Western Blot. Samples: Purified recombinant Adam-TS13. Antibody: ABIN152016 used at the indicated concentrations. Detection: Chemiluminescence with an exposure time of approximately 30 seconds. 100 μL Anmelden zum Anzeigen 2 bis 4 Tage
371,00 €
Details
Human Ziege Unkonjugiert IP, WB 100 μL Anmelden zum Anzeigen 2 bis 4 Tage
371,00 €
Details
Human Ziege Unkonjugiert WB 100 μL Anmelden zum Anzeigen 2 bis 4 Tage
371,00 €
Details
Human Maus Unkonjugiert FACS, IP, WB Detection of ADAMTS13 in HUVEC Human Cells by Flow Cytometry. HUVEC human umbilical vein endothelial cells were stained with Mouse Anti-Human ADAMTS13 Monoclonal Antibody. To facilitate intracellular staining, cells were fixed with paraformaldehyde and permeabilized with saponin. 100 μg Anmelden zum Anzeigen 3 bis 4 Tage
254,00 €
Details
Human Kaninchen Unkonjugiert ELISA, IHC, IHC (p), WB   0.2 mL Anmelden zum Anzeigen 2 bis 4 Tage
311,00 €
Details
Human Kaninchen Unkonjugiert ELISA, WB   100 μg Anmelden zum Anzeigen 8 bis 11 Tage
340,48 €
Details
Human Maus Unkonjugiert ELISA Detection limit for recombinant GST tagged ADAMTS13 is approximately 0.1 ng/mL as a capture antibody. 0.1 mg Anmelden zum Anzeigen 12 bis 16 Tage
454,76 €
Details
Human Maus Unkonjugiert EIA, WB   0.1 mg Anmelden zum Anzeigen 7 bis 9 Tage
440,00 €
Details

ADAMTS13 Antikörper nach Reaktivität, Anwendung, Klonalität and Konjugat

Attribute Applikationen Wirt Klonalität Konjugat
Mouse (Murine) , ,


, , , , , , , , , , , , , ,
Human , , , ,
, , ,
,
, , , , , , , , , , , , , , , , , , ,
Rat (Rattus) , ,


, , , , , , , , , , , , , ,

Am meisten referenzierte anti-ADAMTS13 Antikörper

  1. Human Polyclonal ADAMTS13 Primary Antibody für EIA, IHC (p) - ABIN359601 : Levy, Nichols, Lian, Foroud, McClintick, McGee, Yang, Siemieniak, Stark, Gruppo, Sarode, Shurin, Chandrasekaran, Stabler, Sabio, Bouhassira, Upshaw, Ginsburg, Tsai: Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. in Nature 2001 (PubMed)
    Zeige alle 7 Referenzen für ABIN359601

  2. Human Polyclonal ADAMTS13 Primary Antibody für WB - ABIN152016 : Tao, Wang, Choi, Bernardo, Nishio, Sadler, López, Dong: Cleavage of ultralarge multimers of von Willebrand factor by C-terminal-truncated mutants of ADAMTS-13 under flow. in Blood 2005 (PubMed)
    Zeige alle 5 Referenzen für ABIN152016

  3. Human Polyclonal ADAMTS13 Primary Antibody für ELISA, IHC - ABIN4278265 : Ganburged, Suda, Saito, Yamazaki, Isokawa, Moriyama: Dilated capillaries, disorganized collagen fibers and differential gene expression in periodontal ligaments of hypomorphic fibrillin-1 mice. in Cell and tissue research 2010 (PubMed)
    Zeige alle 3 Referenzen für ABIN4278265

  4. Human Polyclonal ADAMTS13 Primary Antibody für IHC (p), WB - ABIN391641 : Zheng, Chung, Takayama, Majerus, Sadler, Fujikawa: Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. in The Journal of biological chemistry 2001 (PubMed)
    Zeige alle 3 Referenzen für ABIN391641

  5. Human Polyclonal ADAMTS13 Primary Antibody für IP, WB - ABIN251718 : Feng, Eyler, Zhang, Maga, Nester, Kroll, Smith, Afshar-Kharghan: Partial ADAMTS13 deficiency in atypical hemolytic uremic syndrome. in Blood 2013 (PubMed)
    Zeige alle 2 Referenzen für ABIN251718

  6. Human Polyclonal ADAMTS13 Primary Antibody für WB - ABIN251717 : Turner, Nolasco, Ruggeri, Moake: Endothelial cell ADAMTS-13 and VWF: production, release, and VWF string cleavage. in Blood 2009 (PubMed)

Weitere Antikörper gegen ADAMTS13 Interaktionspartner

Mouse (Murine) ADAM Metallopeptidase with Thrombospondin Type 1 Motif, 13 (ADAMTS13) Interaktionspartner

  1. administration of ADAMTS13 5 minutes after occlusion dose-dependently dissolved these t-PA (zeige PLAT Antikörper)-resistant thrombi resulting in fast restoration of MCA (zeige RSPH1 Antikörper) patency and consequently reduced cerebral infarct sizes

  2. Sleeping beauty transposon-mediated gene therapy achieved sustained expression of transgene ADAMTS13 and long-term prophylaxis against congenital thrombotic thrombocytopenic purpura in Adamts13(-/-) mice.

  3. Results also suggest that Toxoplasma gondii-mediated apoptosis might play a pivotal role and a different type of role in the mechanism of neurodegeneration and neuropathology in the process of toxoplasma encephalitis. Furthermore, expression of ADAMTS-13 might give an idea of the progress and is critical for diagnosis of this disease.

  4. Letter: deficiency of ADAMTS13 results in increased formation of venous thrombosis in mice.

  5. ADAMTS13 substrate specificity

  6. Data indicate that the p.D187H mutation impairs ADAMTS13 activity and secretion and may contribute to thrombotic thrombocytopenic purpura.

  7. Data show that metalloendopeptidase (zeige THOP1 Antikörper) ADAMTS13 does not directly promote development of adipose tissue.

  8. findings provide further evidence on the pathophysiological role for the ADAMTS13/VWF (zeige VWF Antikörper) axis in atherosclerosis

  9. Carboxyl terminus of ADAMTS13 directly inhibits platelet aggregation and ultra large von Willebrand factor (zeige VWF Antikörper) string formation under flow in a free-thiol-dependent manner.

  10. The results indicate that the microvascular process induced by ADAMTS13 deficiency triggers complement activation on platelets and the endothelium, which may contribute to formation of thrombotic microangiopathy.

Human ADAM Metallopeptidase with Thrombospondin Type 1 Motif, 13 (ADAMTS13) Interaktionspartner

  1. ADAMTS13 activity and VWF:Ag levels are both associated with an increased risk of all-cause and cardiovascular mortality.

  2. These findings support an ADAMTS13 activation model in which VWF (zeige VWF Antikörper) D4-CK engages the TSP8-CUB2 domains, inducing the conformational change that disrupts the CUB1-spacer domain interaction and thereby activates ADAMTS13

  3. Three cases of systemic lupus erythematosus with ADAMTS13 inhibitor-negative thrombotic microangiopathy were successfully treated with combination of mycophenolate mofetil, plasma exchange and steroid. [case reports]

  4. The pregnancy loss rate does not appear to be affected by both ADAMTS-13 and ADAMTS-19.

  5. Two novel ADAMTS13 mutations (p.I143T and p.Y570C) identified in two adolescence onset congenital thrombotic thrombocytopenic purpura patients were studied. Proteasome degradation of these ADAMTS13 mutants contributed to their reduced secretion.

  6. Correlation between ADAMTS13 activity and neurological impairment in acute thrombotic microangiopathy patients.

  7. review to introduce the state of progress with respect to some of the theorized roles of ADAMTS13[review]

  8. IL-8 (zeige IL8 Antikörper), TNF-alpha (zeige TNF Antikörper), tissue factor (zeige F3 Antikörper), IL-8 (zeige IL8 Antikörper)+tissue factor (zeige F3 Antikörper) and TNF-alpha (zeige TNF Antikörper)+tissue factor (zeige F3 Antikörper) decreased the levels of ADAMTS13 secreted by umbilical vein endothelial cells.

  9. Significantly lower ADAMTS-13 levels and significantly higher VWF (zeige VWF Antikörper) antigen levels were concluded to be the result of a pathological process rather than an etiological factor for Venous thromboembolism.

  10. ADAMTS13 and VWF (zeige VWF Antikörper) are co-expressed in microvascular endothelial cells.

ADAMTS13 Antigen-Profil

Protein Überblick

This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motif) protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The enzyme encoded by this gene is the von Willebrand Factor (vWF)-cleaving protease, which is responsible for cleaving at the site of Tyr842-Met843 of the vWF molecule. A deficiency of this enzyme is associated with thrombotic thrombocytopenic purpura. Alternative splicing of this gene generates multiple transcript variants encoding different isoforms.

Genbezeichner und Symbole assoziert mit ADAMTS13

  • ADAM metallopeptidase with thrombospondin type 1 motif, 13 (ADAMTS13) Antikörper
  • ADAM metallopeptidase with thrombospondin type 1 motif, 13 (adamts13) Antikörper
  • ADAM metallopeptidase with thrombospondin type 1 motif, 13 (LOC100226372) Antikörper
  • ADAM metallopeptidase with thrombospondin type 1 motif, 12 (ADAMTS12) Antikörper
  • a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 13 (Adamts13) Antikörper
  • ADAM metallopeptidase with thrombospondin type 1 motif, 13 (Adamts13) Antikörper
  • ADAM-TS13 Antikörper
  • ADAMTS-13 Antikörper
  • ADAMTS12 Antikörper
  • ADAMTS13 Antikörper
  • C9orf8 Antikörper
  • Gm710 Antikörper
  • vWF-CP Antikörper
  • VWFCP Antikörper

Bezeichner auf Proteinebene für ADAMTS13

ADAM metallopeptidase with thrombospondin type 1 motif, 13 , ADAM metallopeptidase with thrombospondin type 1 motif, 13 isoform 1 preproprotein-like , A disintegrin and metalloproteinase with thrombospondin motifs 13-like , ADAM metallopeptidase with thrombospondin type 1 motif, 12 , A disintegrin and metalloproteinase with thrombospondin motifs 12 , A disintegrin and metalloproteinase with thrombospondin motifs 13 , ADAM-TS 13 , ADAM-TS13 , ADAMTS-13 , ADAMTS13 isoform IAP-b , a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 13 , vWF-CP mRNA for von Willebrand factor-cleaving , vWF-cleaving protease , von Willebrand factor-cleaving protease , a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 13

GENE ID SPEZIES
100069281 Equus caballus
100320289 Danio rerio
100404947 Callithrix jacchus
100481099 Ailuropoda melanoleuca
100226372 Taeniopygia guttata
427428 Gallus gallus
461952 Pan troglodytes
479369 Canis lupus familiaris
525276 Bos taurus
701750 Macaca mulatta
100068281 Equus caballus
279028 Mus musculus
11093 Homo sapiens
100630922 Canis lupus familiaris
532272 Bos taurus
362091 Rattus norvegicus
100343027 Oryctolagus cuniculus
Ausgewählte Anbieter für anti-ADAMTS13 (ADAMTS13) Antikörper
Haben Sie etwas anderes gesucht?